Phase 2 Psoriasis Trial, Recruiting (NCT07410793)

Phase 2 Psoriasis Trial, Recruiting NCT07410793 Sponsor: Mae Fah Luang University Condition: Psoriasis

Printed from Voxsanity (voxsanity.com.au) — NCT07410793 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Psoriasis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with plaque psoriasis affecting your skin, scalp, or nails
You have not received any treatment for psoriasis for at least 4 weeks before the study starts
Your psoriasis is mild to moderate, meaning it covers no more than 10% of your body surface area and your psoriasis severity scores are at or below a certain level (confirm with trial site for exact score details)

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a different type of psoriasis, such as psoriatic arthritis, pustular psoriasis, or erythrodermic psoriasis
You have a serious or poorly controlled health condition affecting your heart, liver, kidneys, or you have cancer
You are currently taking blood-thinning medications, such as aspirin, warfarin, clopidogrel, dabigatran, rivaroxaban, apixaban, or heparin
You have been treated with advanced psoriasis medications called biologics within the past 6 months
You have a fear of needles
You are currently taking medications that suppress the immune system, such as steroid tablets, certain anti-inflammatory drugs, or chemotherapy medications
You are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 16 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +66818092078

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07410793

Sponsor: Mae Fah Luang University

Phase: Phase 2

Status: Recruiting

Condition: Psoriasis

Trial contact: +66818092078

More information: https://clinicaltrials.gov/study/NCT07410793

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with plaque psoriasis affecting your skin, scalp, or nails
You have not received any treatment for psoriasis for at least 4 weeks before the study starts
Your psoriasis is mild to moderate, meaning it covers no more than 10% of your body surface area and your psoriasis severity scores are at or below a certain level (confirm with trial site for exact score details)

Who may not be able to join:

You are currently pregnant or breastfeeding
You have a different type of psoriasis, such as psoriatic arthritis, pustular psoriasis, or erythrodermic psoriasis
You have a serious or poorly controlled health condition affecting your heart, liver, kidneys, or you have cancer
You are currently taking blood-thinning medications, such as aspirin, warfarin, clopidogrel, dabigatran, rivaroxaban, apixaban, or heparin
You have been treated with advanced psoriasis medications called biologics within the past 6 months
You have a fear of needles
You are currently taking medications that suppress the immune system, such as steroid tablets, certain anti-inflammatory drugs, or chemotherapy medications
You are currently taking part in another clinical trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 16 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Mae Fah Luang University

Registry

ClinicalTrials.gov

Start date

9 February 2026

Est. completion

8 February 2027

Where this trial is recruiting

🇹🇭 Thailand

Primary endpoints

Psoriasis Area and Severity Index, PASI score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov